13-106534949-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004093.4(EFNB2):c.16G>A(p.Asp6Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004093.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFNB2 | NM_004093.4 | c.16G>A | p.Asp6Asn | missense_variant | 1/5 | ENST00000646441.1 | |
EFNB2 | NM_001372056.1 | c.16G>A | p.Asp6Asn | missense_variant | 1/4 | ||
EFNB2 | NM_001372057.1 | c.16G>A | p.Asp6Asn | missense_variant | 1/4 | ||
EFNB2 | NM_001372058.1 | c.16G>A | p.Asp6Asn | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFNB2 | ENST00000646441.1 | c.16G>A | p.Asp6Asn | missense_variant | 1/5 | NM_004093.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250326Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135424
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461032Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726816
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | The c.16G>A (p.D6N) alteration is located in exon 1 (coding exon 1) of the EFNB2 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the aspartic acid (D) at amino acid position 6 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at